Authors' Response to Braillon's Comment on: "Limited Evidence for Risk Factors for Proarrhythmia and Sudden Cardiac Death in Patients Using Antidepressants: Dutch Consensus on ECG Monitoring"

Drug Saf. 2018 Dec;41(12):1417-1418. doi: 10.1007/s40264-018-0716-5.

Mirjam Simoons^{1

2

3}, Adrie Seldenrijk^{2

4}, Hans Mulder^{1

5}, Eric van Roon^{3

6}, Roberto Bakker^{7

8}, Henricus Ruhé^{9

10

11}

¹ Department of Clinical Pharmacy, Wilhelmina Hospital Assen, Assen, The Netherlands.
² Department of Psychiatry, Radboudumc, PO-Box 9101, 6500 HB, Nijmegen, The Netherlands.
³ Unit of Pharmacotherapy, Epidemiology and-Economics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands.
⁴ Department of Research and Innovation, GGZ InGeest, Amsterdam, The Netherlands.
⁵ Psychiatric Hospital GGZ Drenthe, Assen, The Netherlands.
⁶ Department of Clinical Pharmacy and Clinical Pharmacology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
⁷ Psychiatric Centre GGz Centraal, Amersfoort, The Netherlands.
⁸ Department of Psychiatry and Psychology, South Limburg Mental Health and Teaching Network, Maastricht University Medical Centre, Maastricht, The Netherlands.
⁹ Department of Psychiatry, Radboudumc, PO-Box 9101, 6500 HB, Nijmegen, The Netherlands. eric.ruhe@radboudumc.nl.
¹⁰ Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK. eric.ruhe@radboudumc.nl.
¹¹ Department of Psychiatry, Radboudumc, Nijmegen, The Netherlands. eric.ruhe@radboudumc.nl.

No abstract available

Publication types